Jacobi Capital Management LLC Emergent Bio Solutions Inc. Transaction History

Jacobi Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $331 - $550	-10 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$50.07 - $66.05 $13,218 - $17,437	-264 Reduced 96.35%	10 $1,000
Q2 2021 Aug 12, 2021	BUY	$56.61 - $80.46 $4,075 - $5,793	72 Added 35.64%	274 $17,000
Q1 2021 May 11, 2021	BUY	$86.23 - $125.19 $7,243 - $10,515	84 Added 71.19%	202 $19,000
Q4 2020 Feb 08, 2021	BUY	$79.17 - $111.47 $1,425 - $2,006	18 Added 18.0%	118 $11,000
Q3 2020 Oct 30, 2020	BUY	$81.91 - $134.94 $8,191 - $13,494	100 New	100 $10,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.